Edgewise Therapeutics Inc (EWTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -167,795 | -133,813 | -100,163 | -67,640 | -42,813 |
| Depreciation Amortization | -5,399 | -10,255 | -7,785 | -5 | 272 |
| Accounts payable and accrued liabilities | 272 | 1,737 | -92 | 47 | 2,654 |
| Other Working Capital | -5,374 | 10,328 | -1,560 | 4,086 | 4,630 |
| Other Operating Activity | 34,480 | 22,975 | 17,652 | 10,877 | 1,750 |
| Operating Cash Flow | $-143,816 | $-109,028 | $-91,948 | $-52,635 | $-33,507 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -256 | -1,312 | -5,745 | -5,546 | -668 |
| Purchase Of Investment | -527,226 | -477,055 | -255,866 | -95,605 | -245,003 |
| Sale Of Investment | 494,692 | 293,711 | 364,497 | 30,574 | 3,444 |
| Investing Cash Flow | $-32,790 | $-184,656 | $102,886 | $-70,577 | $-242,227 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 196,088 | 249,515 | 53,331 | 129,890 | 360 |
| Other Financing Activity | 0 | -262 | -165 | -251 | 186,024 |
| Financing Cash Flow | $196,088 | $249,253 | $53,166 | $129,639 | $186,384 |
| Beginning Cash Position | 41,666 | 86,097 | 21,993 | 15,566 | 104,916 |
| End Cash Position | 61,148 | 41,666 | 86,097 | 21,993 | 15,566 |
| Net Cash Flow | $19,482 | $-44,431 | $64,104 | $6,427 | $-89,350 |
| Free Cash Flow | |||||
| Operating Cash Flow | -143,816 | -109,028 | -91,948 | -52,635 | -33,507 |
| Capital Expenditure | -256 | -1,312 | -5,745 | -5,546 | -668 |
| Free Cash Flow | -144,072 | -110,340 | -97,693 | -58,181 | -34,175 |